Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis

PURPOSE: The purpose of this study was to evaluate the efficacy and safety of induction chemotherapy with docetaxel, capecitabine, and cisplatin (DXP) plus bevacizumab (BEV) on initially unresectable locally advanced gastric cancer (LAGC) or paraaortic lymph node (PAN) metastatic gastric cancer (GC)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Res Treat
Egile Nagusiak: Kim, Jwa Hoon, Park, Sook Ryun, Ryu, Min-Hee, Ryoo, Baek-Yeol, Kim, Kyu-pyo, Kim, Beom Su, Yoo, Moon-Won, Yook, Jeong Hwan, Kim, Byung Sik, Kim, Jihun, Byeon, Sun-Ju, Kang, Yoon-Koo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Cancer Association 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5912143/
https://ncbi.nlm.nih.gov/pubmed/28546521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2017.005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak